Showing results (241-250 of 290) with videos related to

Sort By:
Pageof 29
American Journal of Obstetrics and Gynecology|March 1, 1993
Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curveK A Yedema, R H Verheijen, P Kenemans, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1990
Comparison of large volume culture to other methods for isolation of microorganisms from dialysateD L Sewell, T A Golper, P B Hulman, et al.
Molekuliarnaia Biologiia|November 8, 2006
[Nah-plasmids of IncP-9 group from natural strains of Pseudomonas]A A Levchuk, I M Bulyga, T Iu Izmalkova, et al.
The American Journal of Clinical Nutrition|January 30, 1999
Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trialI A Brouwer, M van Dusseldorp, C M Thomas, et al.
Molecular Microbiology|May 13, 1999
Repression at a distance by the global regulator KorB of promiscuous IncP plasmidsG Jagura-Burdzy, D P Macartney, M Zatyka, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgeryC A Yedema, P Kenemans, C M Thomas, et al.
British Journal of Urology|November 1, 1996
Clinical implications of the rise and fall of prostate specific antigen after laser prostatectomyM P van Iersel, C M Thomas, W P Witjes, et al.
The British Journal of Nutrition|April 1, 2000
Low-dose folic acid supplementation does not influence plasma methionine concentrations in young non-pregnant womenI A Brouwer, M van Dusseldorp, M Duran, et al.
Human Reproduction (Oxford, England)|June 2, 2001
Semen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: an effort towards standardization of in-vivo thresholdsR Menkveld, W Y Wong, C J Lombard, et al.
Nuclear Medicine Communications|October 1, 1995
Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patientsJ G Tibben, C M Thomas, L F Massuger, et al.
Pageof 29